Your browser doesn't support javascript.
loading
The EHA Research Roadmap: Malignant Lymphoid Diseases.
Dreyling, Martin; André, Marc; Gökbuget, Nicola; Tilly, Hervé; Jerkeman, Mats; Gribben, John; Ferreri, Andrés; Morel, Pierre; Stilgenbauer, Stephan; Fox, Christopher; Maria Ribera, José; Zweegman, Sonja; Aurer, Igor; Bödör, Csaba; Burkhardt, Birgit; Buske, Christian; Dollores Caballero, Maria; Campo, Elias; Chapuy, Bjoern; Davies, Andrew; de Leval, Laurence; Doorduijn, Jeanette; Federico, Massimo; Gaulard, Philippe; Gay, Francesca; Ghia, Paolo; Grønbæk, Kirsten; Goldschmidt, Hartmut; Kersten, Marie-Jose; Kiesewetter, Barbara; Landman-Parker, Judith; Le Gouill, Steven; Lenz, Georg; Leppä, Sirpa; Lopez-Guillermo, Armando; Macintyre, Elizabeth; Mantega, Maria Victoria Mateos; Moreau, Philippe; Moreno, Carol; Nadel, Bertrand; Okosun, Jessica; Owen, Roger; Pospisilova, Sarka; Pott, Christiane; Robak, Tadeusz; Spina, Michelle; Stamatopoulos, Kostas; Stary, Jan; Tarte, Karin; Tedeschi, Allessandra.
Affiliation
  • Dreyling M; Department of Medicine III, LMU Hospital, Munich, Germany.
  • André M; Université Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium.
  • Gökbuget N; Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
  • Tilly H; INSERM U1245, Department of Hematology, Centre Henri Becquerel and Université de Rouen, France.
  • Jerkeman M; Skåne University and Lund University, Lund, Sweden.
  • Gribben J; Barts Cancer Institute, Queen Mary University of London, United Kingdom.
  • Ferreri A; Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Morel P; Service Hematologie Clinique Therapie Cellulaire, CHU Amiens Picardie, Amiens, France.
  • Stilgenbauer S; Comprehensive Cancer Center Ulm (CCCU), Sektion CLL Klinik für Innere Medizin III, Universität Ulm, Germany.
  • Fox C; School of Medicine, University of Nottingham, United Kingdom.
  • Maria Ribera J; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain.
  • Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • Aurer I; University Hospital Centre Zagreb and Medical School, University of Zagreb, Croatia.
  • Bödör C; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Burkhardt B; Experimentelle und Translationale päd. Hämatologie u Onkologie, Leitung der Bereiche Lymphome und Stammzelltransplantation, Universitätsklinikum Münster (UKM), Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Munich, Germany.
  • Buske C; Institute of Experimental Cancer Research, CCC Ulm, University Hospital Ulm, Germany.
  • Dollores Caballero M; Clinical and Transplant Unit, University Hospital of Salamanca, Spain.
  • Campo E; Department of Medicine at the University of Salamanca, Spain.
  • Chapuy B; El Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
  • Davies A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • de Leval L; Department of Hematology, Oncology and Tumor Immunology, Charité, University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany.
  • Doorduijn J; Berlin Institute of Health, Berlin, Germany.
  • Federico M; Southampton NCRI/UK Experimental Cancer Medicines Centre, Faculty of Medicine, University of Southampton, United Kingdom.
  • Gaulard P; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
  • Gay F; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Ghia P; Città di Lecce Hospital, GVM Care & Research, Lecce, Italy.
  • Grønbæk K; Département de Pathologie, Hôpital Henri Mondor, AP-HP, Créteil, France.
  • Goldschmidt H; Clinical Trial Unit, Division of Hematology 1, AOU Città Della Salute e Della Scienza, University of Torino, Italy.
  • Kersten MJ; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
  • Kiesewetter B; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Landman-Parker J; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark.
  • Le Gouill S; University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Lenz G; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, the Netherlands.
  • Leppä S; Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria.
  • Lopez-Guillermo A; Pediatric Hematology Oncology, Sorbonne Université APHP/hôpital A Trousseau, Paris, France.
  • Macintyre E; Service d'Hématologie, Clinique du Centre Hospitalier Universitaire (CHU) de Nantes, France.
  • Mantega MVM; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Germany.
  • Moreau P; University of Helsinki and Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland.
  • Moreno C; Department of Hematology, Hospital Clínic de Barcelona, Spain.
  • Nadel B; Onco-hematology, Université de Paris and Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, France.
  • Okosun J; Complejo Asistencial Universitario de Salamanca, IBSAL, CIC, Universidad de Salamanca, Ciberonc, Salamanca, Spain.
  • Owen R; Hematology Department, University Hospital Hotel-Dieu, Nantes, France.
  • Pospisilova S; Hospital de la Santa Creu I Sant Pau, Autonomous University of Barcelona, Spain.
  • Pott C; Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.
  • Robak T; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom.
  • Spina M; St James's Institute of Oncology, Leeds, United Kingdom.
  • Stamatopoulos K; Department of Internal Medicine-Hematology and Oncology and Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Czech Republic.
  • Stary J; Klinisch-experimentelle Hämatologie, Medizinische Klinik II, Hämatologie und Internistische Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany.
  • Tarte K; Medical University of Lodz, Poland.
  • Tedeschi A; Division of Medical Oncology and Immune-related Tumors, National Cancer Institute, Aviano, Italy.
Hemasphere ; 6(6): e726, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35620592
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States